Farber, Harrison W.

Predicting Survival in Patients With Pulmonary Arterial Hypertension

Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D., et al. (2019) · Chest

Pulmonary Hypertension Research and TreatmentsVascular Anomalies and Treatments

Cited by 643

Cellular glutathione peroxidase deficiency and endothelial dysfunction

Forgione, M. A., Weiss, N., Heydrick, S., Cap, A., Klings, E. S., Bierl, C., Eberhardt, R. T., Farber, H. W., & Loscalzo, J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology

Nitric Oxide and Endothelin EffectsRedox biology and oxidative stress

Cited by 199

Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease

Klings, E. S., & Farber, H. W. (2001) · Respiratory Research

Hemoglobinopathies and Related DisordersNitric Oxide and Endothelin Effects

Cited by 132

Impact of declining renal function on outcomes in pulmonary arterial hypertension: a REVEAL registry analysis

Chakinala, M. M., Coyne, D. W., Benza, R. L., Frost, A. E., McGoon, M. D., Hartline, B. K., Frantz, R. P., Selej, M., Zhao, C., Mink, D. R., et al. (2018) · The Journal of Heart and Lung Transplantation

Pulmonary Hypertension Research and TreatmentsHeart Failure Treatment and Management

Cited by 48